Description

CJC-1295 with DAC (Growth Hormone-Releasing Hormone Analogue)

Description

CJC-1295 with DAC is a synthetic analogue of Growth Hormone-Releasing Hormone that incorporates a Drug Affinity Complex (DAC) to significantly extend its half-life. It is studied for its ability to stimulate the natural release of growth hormone (GH) and increase insulin-like growth factor-1 (IGF-1) levels over an extended period.

Unlike CJC-1295 without DAC, the DAC-modified version is designed for prolonged activity, making it a subject of research focused on sustained growth hormone secretion, metabolic function, recovery, and body composition.

Key benefits (research findings)

Stimulates endogenous growth hormone release through GHRH receptor activation.
Produces sustained elevations in growth hormone and IGF-1 due to its extended half-life.
Studied for potential effects on muscle recovery, body composition, and tissue repair.
May support metabolic function and protein synthesis in experimental models.

Who it’s for

Researchers investigating growth hormone physiology, recovery mechanisms, body composition, and metabolic regulation.
Intended strictly for laboratory and investigational use; not for individual or unsupervised administration.

Suggested use

Administered in controlled research settings according to established study protocols.
Experimental dosing schedules and administration frequency vary depending on research objectives and protocol design due to the compound’s extended duration of action.

Safety and storage

Research observations may include injection-site irritation, flushing, water retention, headache, or transient hormonal fluctuations depending on study conditions.
Proper laboratory safety procedures and sterile handling techniques should always be followed.
Store according to manufacturer or protocol recommendations (typically refrigerated and protected from light) to maintain peptide stability.

Quick facts

Mechanism: Growth Hormone-Releasing Hormone (GHRH) receptor agonist with an extended half-life provided by the Drug Affinity Complex (DAC).
Status: Investigational research peptide; not approved for therapeutic use.
Studied for: Growth hormone secretion, IGF-1 production, recovery, body composition, metabolism, and regenerative research.

Research Use Only Disclaimer

Products sold by SoCo Peptides are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, veterinary use, household use, cosmetic use, or therapeutic application. They are not drugs, foods, or dietary supplements and have not been evaluated or approved by the FDA.

By purchasing from this website, the customer represents that they are a qualified researcher or laboratory professional and understand the risks associated with handling research materials.

All products must be handled by trained professionals in appropriate research facilities and in accordance with all applicable laws and regulations.

SoCo Peptides makes no guarantees or claims regarding safety, effectiveness, or medical benefit.